Autosomal Dominant Polycystic Kidney Disease and Intracranial Aneurysms: Is There an Increased Risk of Treatment?

References

1. 1.↵
   2. Schievink WI,
   3. Torres VE,
   4. Piepgras DG, et al

   . Saccular intracranial aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1992;3:88–95 pmid:1391712

   Abstract
2. 2.↵
   2. Chapman AB,
   3. Rubinstein D,
   4. Hughes R, et al

   . Intracranial aneurysms in autosomal dominant polycystic kidney disease. N Engl J Med 1992;327:916–20 doi:10.1056/NEJM199209243271303 pmid:1513348

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Huston J 3rd.,
   3. Torres VE,
   4. Sulivan PP, et al

   . Value of magnetic resonance angiography for the detection of intracranial aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1993;3:1871–77 pmid:8338918

   Abstract
4. 4.↵
   2. Rinkel GJ,
   3. Djibuti M,
   4. Algra A, et al

   . Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke 1998;29:251–56 doi:10.1161/01.STR.29.1.251 pmid:9445359

   Abstract/FREE Full Text
5. 5.↵
   2. Ruggieri PM,
   3. Poulos N,
   4. Masaryk TJ, et al

   . Occult intracranial aneurysms in polycystic kidney disease: screening with MR angiography. Radiology 1994;191:33–39 doi:10.1148/radiology.191.1.8134594 pmid:8134594

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Graf S,
   3. Schischma A,
   4. Eberhardt KE, et al

   . Intracranial aneurysms and dolichoectasia in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 2002;17:819–23 doi:10.1093/ndt/17.5.819 pmid:11981069

   Abstract/FREE Full Text
7. 7.↵
   2. de la Monte SM,
   3. Moore GW,
   4. Monk MA, et al

   . Risk factors for the development and rupture of intracranial berry aneurysms. Am J Med 1985;78:957–64 doi:10.1016/0002-9343(85)90218-9 pmid:4014270

   CrossRefPubMed
8. 8.↵
   2. Inagawa T,
   3. Hirano A

   . Autopsy study of unruptured incidental intracranial aneurysms. Surg Neurol 1990;34:361–65 doi:10.1016/0090-3019(90)90237-J pmid:2244298

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Fox JL

   2. Fox JL

   . The incidence of intracranial aneurysm. In: Fox JL, ed. Intracranial Aneurysms. New York: Springer-Verlag; 1983:15–18
10. 10.↵
    2. Stehbens WE

    . Pathology of the Cerebral Blood Vessels. St. Louis: Mosby; 1972:351–470
11. 11.↵
    2. Lozano AM,
    3. Leblanc R

    . Cerebral aneurysms and polycystic kidney disease: a critical review. Can J Neurol Sci 1992;19:222–27 pmid:1623450

    PubMedWeb of Science
12. 12.↵
    2. Chauveau D,
    3. Pirson Y,
    4. Verellen-Dumoulin C, et al

    . Intracranial aneurysms in autosomal dominant polycystic kidney disease. Kidney Int 1994;45:1140–46 doi:10.1038/ki.1994.151 pmid:8007584

    CrossRefPubMedWeb of Science
13. 13.↵
    2. Chapman AB,
    3. Johnson AM,
    4. Gabow PA

    . Intracranial aneurysms in patients with autosomal dominant polycystic kidney disease: how to diagnose and who to screen. Am J Kidney Dis 1993;22:526–31 doi:10.1016/S0272-6386(12)80924-3 pmid:8213791

    CrossRefPubMed
14. 14.↵
    2. Hop JW,
    3. Rinkel GJ,
    4. Algra A, et al

    . Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke 1997;28:660–64 doi:10.1161/01.STR.28.3.660 pmid:9056628

    Abstract/FREE Full Text
15. 15.↵
    ACROSS Group. Epidemiology of aneurysmal subarachnoid hemorrhage in Australia and New Zealand: incidence and case fatality from the Australasian Cooperative Research on Subarachnoid Hemorrhage Study (ACROSS). Stroke 2000;31:1843–50 doi:10.1161/01.STR.31.8.1843 pmid:10926945

    Abstract/FREE Full Text
16. 16.↵
    2. Bichet D,
    3. Peters D,
    4. Patel AJ, et al

    . Cardiovascular polycystins: insights from autosomal dominant polycystic kidney disease and transgenic animal models. Trends Cardiovasc Med 2006;16:292–98 doi:10.1016/j.tcm.2006.07.002 pmid:17055386

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Kip SN,
    3. Hunter LW,
    4. Ren Q, et al

    . [Ca2+]i reduction increases cellular proliferation and apoptosis in vascular smooth muscle cells: relevance to the ADPKD phenotype. Circ Res 2005;96:873–80 doi:10.1161/01.RES.0000163278.68142.8a pmid:15790956

    Abstract/FREE Full Text
18. 18.↵
    2. Hassane S,
    3. Claij N,
    4. Lantinga-van Leeuwen IS, et al

    . Pathogenic sequence for dissecting aneurysm formation in a hypomorphic polycystic kidney disease 1 mouse model. Arterioscler Thromb Vasc Biol 2007;27:2177–83 doi:10.1161/ATVBAHA.107.149252 pmid:17656674

    Abstract/FREE Full Text
19. 19.↵
    2. Bobrie G,
    3. Brunet-Bourgin F,
    4. Alamowitch S, et al

    . Spontaneous artery dissection: is it part of the spectrum of autosomal dominant polycystic kidney disease? Nephrol Dial Transplant 1998;13:2138–41 doi:10.1093/ndt/13.8.2138 pmid:9719186

    Abstract/FREE Full Text
20. 20.↵
    2. Itty CT,
    3. Farshid A,
    4. Talaulikar G

    . Spontaneous coronary artery dissection in a woman with polycystic kidney disease. Am J Kidney Dis 2009;53:518–21 doi:10.1053/j.ajkd.2008.08.027 pmid:18992981

    CrossRefPubMedWeb of Science
21. 21.↵
    2. Wiebers DO,
    3. Whisnant JP,
    4. Huston J 3rd., et al

    ; International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 2003;362:103–10 doi:10.1016/S0140-6736(03)13860-3 pmid:12867109

    CrossRefPubMedWeb of Science
22. 22.↵
    2. Naggara ON,
    3. Lecler A,
    4. Oppenheim C, et al

    . Endovascular treatment of intracranial unruptured aneurysms: a systematic review of the literature on safety with emphasis on subgroup analyses. Radiology 2012;263:828–35 doi:10.1148/radiol.12112114 pmid:22623696

    CrossRefPubMedWeb of Science
23. 23.↵
    2. Brinjikji W,
    3. Rabinstein AA,
    4. Nasr DM, et al

    . Better outcomes with treatment by coiling relative to clipping of unruptured intracranial aneurysms in the United States, 2001–2008. AJNR Am J Neuroradiol 2011;32:1071–75 doi:10.3174/ajnr.A2453 pmid:21511860

    Abstract/FREE Full Text
24. 24.↵
    1. Henriksen K,
    2. Battles JB,
    3. Keyes MA, et al.

    2. Hougland P,
    3. Nebeker J,
    4. Pickard S, et al

    . Using ICD-9-CM codes in hospital claims data to detect adverse events in patient safety surveillance. In: Henriksen K, Battles JB, Keyes MA, et al., eds. Advances in Patient Safety: New Directions and Alternative Approaches. Vol. 1: Assessment. Rockville: Agency for Healthcare Research and Quality; 2008. http://www.ncbi.nlm.nih.gov/books/NBK43647/. Accessed September 14, 2014.